Zobrazeno 1 - 10
of 90
pro vyhledávání: '"Factor VIII assay"'
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 10, Iss 1, Pp EC04-EC06 (2016)
Introduction: Thrombotic disorders have been found to be associated with recurrent abortions. Several risk factors have been identified. APTT reflects the common pathway and intrinsic pathway of coagulation cascade and hence is a good marker for
Externí odkaz:
https://doaj.org/article/584f36ab6ed94133a743bfb5cb036e2e
Publikováno v:
Vox Sanguinis. 115:192-199
BACKGROUND Acquired haemophilia A (AHA), with potentially high risk of morbidity and mortality, occurs as a result of inhibitors against factor VIII. Bleeding due to AHA can be treated with activated prothrombin complex concentrate (aPCC), recombinan
Autor:
Basak Koc, Emre Akkaya, Ayşegül Ünüvar, Serap Karaman, Zeynep Karakas, Beyhan Omer, Bulent Zulfikar, Sema Genc, Songul Hatiboglu
Publikováno v:
Clinical laboratory. 66(10)
Congenital factor VIII (FVIII) deficiency causes hemophilia A due to different types of defects in the FVIII gene. Although the chromogenic measurement is the reference method and shows less variability, a one-stage assay is the most commonly preferr
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Seminars in Thrombosis and Hemostasis. 43:331-337
The advent of modified factor VIII (FVIII) and factor IX (FIX) molecules with extended half-lives (EHLs) compared with native FVIII and FIX represents a major advance in the field of hemophilia care, with the potential to reduce the frequency of prop
Publikováno v:
Blood. 134:906-906
Introduction Hemophilia A is an X-linked inherited bleeding disorder characterized by a deficiency of coagulation factor VIII (FVIII). FVIII assays used for diagnosis and classification of hemophilia are the widely used one-stage assay (OSA) and the
Autor:
Abiola Bolarinwa, Oluwakemi Otokiti
Publikováno v:
American Journal of Clinical Pathology. 154:S166-S166
Introduction/Objective cryopecipiitate is of huge importance in the management of some Bleeding disorders especially in a low resource settings like ours where it is still the mainstay of management of disseminated Intravsacular coagulopathy, Haemoph
Autor:
Steve Kitchen, Timothy A. L. Woods, Dianne P. Kitchen, Ian Jennings, Michael Makris, Isobel D. Walker
Publikováno v:
International journal of laboratory hematology. 41(2)
INTRODUCTION: Variability in FVIII measurement is a recognized problem. There are limited data for samples containing recombinant Factor VIII Fc fusion protein (rFVIIIFc). Many studies use samples for which factor concentrate has been spiked into FVI
Autor:
Amy E. Schmidt, Marisa B. Marques
Publikováno v:
Hematologic Challenges in the Critically Ill ISBN: 9783319935713
Critically ill patients undergo numerous laboratory tests to better understand their disease processes and track their illnesses. Many critically ill patients have a variety of conditions such as anemia, sepsis, multiorgan failure, coagulopathies, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c41bfa2020b64f610434a4e25d1ad1f2
https://doi.org/10.1007/978-3-319-93572-0_3
https://doi.org/10.1007/978-3-319-93572-0_3
Autor:
Elizabeth M. Duncan, Susan E. Rodgers
Publikováno v:
Methods in Molecular Biology ISBN: 9781493971947
Hemophilia A is an inherited bleeding disorder caused by a reduced level of factor VIII coagulant activity (FVIII:C) in blood. Bleeding episodes may occur spontaneously in the severe form of hemophilia or after trauma in the milder forms. It is impor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2bbe4c60472ecb7c8d33aeda5985519f
https://doi.org/10.1007/978-1-4939-7196-1_21
https://doi.org/10.1007/978-1-4939-7196-1_21